OPKO Health (OPK) acquires Laboratorio Arama de Uruguay. Terms were undisclosed, with closing expected in Jan.
CEO Phillip Frost: "This acquisition will allow OPKO to establish a footprint in Uruguay and facilitate future sales and commercial expansion into neighboring Argentina. In the near term, Arama provides another platform for the commercialization of our 4Kscore."
OPK shares +4.9% AH